Skip to content

Reinforcing Effects of MDMA (‘Ecstasy’) in Drug-Naive and Cocaine-Trained Rats

Elisabeth Ratzenboeck, Alois Saria, Norbert Kriechbaum, Gerald Zernig

Pharmacology January 1, 2001 DOI: 10.1159/000056086 via OpenAlex

Summary

AI-generated from the abstract

MDMA (ecstasy) is a common illegal drug among European adolescents who are typically inexperienced with hard drugs like cocaine. In rats, the reinforcing effect of intravenously self-administered MDMA did not differ between drug-naive animals and those previously trained with cocaine. MDMA sensitized rats to its own rate-increasing effect but not to that of cocaine. No carryover of cocaine's reinforcing effect to MDMA was observed, indicating that MDMA and cocaine produce distinct interoceptive stimuli in rats.

Study at a glance

Characteristics Experimental study Peer reviewed
Population Rats
Interventions MDMA cocaine
Dose 0.032–10 mg/(kg·injection)
Topics Addiction MDMA
Keywords Hallucinogen Psychology Pharmacology
Citations 97
Key finding MDMA's reinforcing effect did not differ between drug-naive and cocaine-trained rats, and MDMA and cocaine produce distinct interoceptive stimuli.

Abstract

3,4-Methylenedioxymethamphetamine (MDMA; ‘ecstasy’) is one of the most prevalent illegal drugs of abuse among European adolescents, a population not generally experienced with respect to ‘hard’ drugs such as cocaine. We, therefore, determined the reinforcing effect of intravenously self-administered MDMA in a fixed ratio 1 time-out 150 s schedule of reinforcement in rats that were truly drug naive and compared it to cocaine-trained rats. The reinforcing effect of MDMA [0.032–10 mg/(kg·injection)] did not differ between drug-naive rats and cocaine-trained ones. MDMA sensitized the animals to its own rate-increasing effect but not to that of cocaine. When MDMA was tested after cocaine, there was no carryover of cocaine’s reinforcing effect to that of MDMA, suggesting that MDMA and cocaine produce distinct interoceptive stimuli in rats.

Explore topics

Comments

No comments yet.

Log in to comment